🧪 UPDATED DAILY FROM CLINICALTRIALS.GOVSynced today

Find Clinical Trials for Your Rare Disease

12059+ recruiting trials across all rare diseases. Filter by phase, location, and condition.

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Showing 20 of 12059 recruiting trials

Enrolling by InvitationNCT06691464

FAPI PET/CT to Detect Fibroblast Activity in Non-resolving ARDS

🏥 University Medical Center Groningen📍 1 site📅 Started Sep 2024View details ↗
NAEnrolling by InvitationNCT07088705

Subthreshold Micropulse Laser Therapy (SML) in Retinitis Pigmentosa

🏥 Marta P. Wiącek📍 1 site📅 Started Sep 2024View details ↗
Phase 2RecruitingNCT06852287

Phase II Clinical Study of GemOX Hepatic Arterial Infusion Combined with Lenvatinib and Toripalimab for Advanced and Unresectable Intrahepatic Cholangiocarcinoma and Gallbladder Cancer

🏥 Tianjin Medical University Cancer Institute and Hospital📍 1 site📅 Started Sep 2024View details ↗
NAEnrolling by InvitationNCT06335862

Primary Posterior Tracheopexy Prevents Tracheal Collapse

👨‍⚕️ John Vlot, MD, PhD, Erasmus Medical Center📍 3 sites📅 Started Sep 2024View details ↗
RecruitingNCT06718972

A Real-world Study on the Treatment of Non-small Cell Lung Cancer With Leptomeningeal Metastasis in China

🏥 Guangzhou Medical University📍 2 sites📅 Started Sep 2024View details ↗
RecruitingNCT06572826

Cardiac Rehabilitation in Patients Acutely Managed for Cardiogenic Shock (ENIGMA)

🏥 Fondazione Don Carlo Gnocchi Onlus📍 1 site📅 Started Aug 2024View details ↗
Phase 2RecruitingNCT06554600

A Study of Zanubrutinib in Combination With Polatuzumab Vedotin, Bendamustine and Rituximab in the Treatment of Relapsed/Refractory Diffuse Large B-cell Lymphoma

🏥 Second Affiliated Hospital, School of Medicine, Zhejiang University📍 1 site📅 Started Aug 2024View details ↗
Phase 1, PHASE2RecruitingNCT06554561

A Study of Pomadomide in Combination With Rituximab and Methotrexate for Newly-diagnosed Primary Central Nervous System Lymphoma

🏥 Second Affiliated Hospital, School of Medicine, Zhejiang University📍 1 site📅 Started Aug 2024View details ↗
Phase 1, PHASE2RecruitingNCT06556199

A Study of Selinexor in Combination With Temozolomide and Anti-PD-1 Antibody in Patients With Relapsed/Refractory Primary Central Nervous System Lymphoma

🏥 Second Affiliated Hospital, School of Medicine, Zhejiang University📍 1 site📅 Started Aug 2024View details ↗
RecruitingNCT06915649

Exploration and Evaluation of Amygdalo-Hippocampectomy According to Prof. Coubes' Technique: An Anatomical, Clinical, and Educational Approach

👨‍⚕️ Gaetan POULEN, MD, PhD, CHU de MONTPELLIER, FRANCE📍 1 site📅 Started Aug 2024View details ↗
NARecruitingNCT06551909

Radioimmunotherapy in Solid Tumors (PNRR-MCNT2-2023-12378239-Aim2)

👨‍⚕️ Nadia G Di Muzio, Prof, IRCCS San Raffaele Scientific Institute📍 1 site📅 Started Aug 2024View details ↗
Phase 1RecruitingNCT06787989

BCMA-CD19 CCAR T Cell Treatment of Refractory Immune Thrombocytopenia Associated with Autoimmune Diseases

🏥 iCell Gene Therapeutics📍 1 site📅 Started Aug 2024View details ↗
Phase 2RecruitingNCT06438822

Cadonilimab Combined With Liposomal Irinotecan Plus Leucovorin and Fluorouracil for Advanced Cholangiocarcinoma

🏥 West China Hospital📍 1 site📅 Started Aug 2024View details ↗
NARecruitingNCT06723522

High Definition Transcranial Direct Current Stimulation of Right Inferior Frontal Gyrus to Improve Social Impairments in Children with Autism

🏥 Central South University📍 1 site📅 Started Aug 2024View details ↗
Phase 3RecruitingNCT06932744

Study of Safety and Efficacy of MY008211A in Paroxysmal Nocturnal Hemoglobinuria (PNH) Patients Who Are Naive to Complement Inhibitor Therapy

🏥 Wuhan Createrna Science and Technology Co., Ltd📍 2 sites📅 Started Aug 2024View details ↗
RecruitingNCT06764511

Evaluation of Response to Biosimilar Erythropoietin Alfa Therapy in Anemic Patients With Myelodysplastic Syndrome

👨‍⚕️ Stefania Paolini, MD, IRCCS Azienda Ospedaliero-Universitaria di Bologna📍 1 site📅 Started Aug 2024View details ↗
Phase 3RecruitingNCT06932471

Study of Safety and Efficacy of MY008211A in Patients With Residual Anemia Despite Anti-C5 Antibody Treatment

🏥 Wuhan Createrna Science and Technology Co., Ltd📍 1 site📅 Started Aug 2024View details ↗
NARecruitingNCT06722638

Virtual Reality During Lumbar Punctures in Acute Lymphoblastic Leukemia

🏥 Children's National Research Institute📍 1 site📅 Started Aug 2024View details ↗
EARLY_Phase 1RecruitingNCT06337474

An Clinical Study of CD19 CAR NK Cells for the Treatment of Refractory Primary Immune Thrombocytopenia

🏥 Changzhou No.2 People's Hospital📍 1 site📅 Started Aug 2024View details ↗
RecruitingNCT06608888

Unveiling the Neural Mechanisms of 5-HT7 in Sleep Apnea Induced by Arousal Dysregulation

👨‍⚕️ Jingying Ye, BeijingTsinghua Changgung Hospital,Tsinghua University📍 1 site📅 Started Aug 2024View details ↗
← PreviousPage 249 of 603Next →

Get alerts when new trials open

Create a free account to follow conditions and receive trial notifications.

Create free account →